nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—CYP3A4—bone cancer	0.925	1	CbGaD
Chlorphenamine—SLC22A2—Cisplatin—bone cancer	0.04	0.784	CbGbCtD
Chlorphenamine—CYP2D6—Doxorubicin—bone cancer	0.00672	0.132	CbGbCtD
Chlorphenamine—CYP3A4—Doxorubicin—bone cancer	0.00427	0.0838	CbGbCtD
Chlorphenamine—Clomipramine—GSTP1—bone cancer	0.00122	0.277	CrCbGaD
Chlorphenamine—Tolterodine—CYP3A4—bone cancer	0.000716	0.163	CrCbGaD
Chlorphenamine—Carbinoxamine—CYP3A4—bone cancer	0.000615	0.14	CrCbGaD
Chlorphenamine—Hyporeflexia—Epirubicin—bone cancer	0.000596	0.0312	CcSEcCtD
Chlorphenamine—Hyporeflexia—Doxorubicin—bone cancer	0.000551	0.0288	CcSEcCtD
Chlorphenamine—Brompheniramine—CYP3A4—bone cancer	0.000532	0.121	CrCbGaD
Chlorphenamine—Wheezing—Cisplatin—bone cancer	0.000512	0.0268	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Cisplatin—bone cancer	0.000424	0.0222	CcSEcCtD
Chlorphenamine—Nasal congestion—Cisplatin—bone cancer	0.00042	0.022	CcSEcCtD
Chlorphenamine—Clomipramine—CYP3A4—bone cancer	0.000393	0.0896	CrCbGaD
Chlorphenamine—Irritability—Cisplatin—bone cancer	0.000365	0.0191	CcSEcCtD
Chlorphenamine—Neuritis—Epirubicin—bone cancer	0.000363	0.019	CcSEcCtD
Chlorphenamine—Neuritis—Doxorubicin—bone cancer	0.000336	0.0176	CcSEcCtD
Chlorphenamine—Orphenadrine—CYP3A4—bone cancer	0.000335	0.0765	CrCbGaD
Chlorphenamine—Sweating increased—Cisplatin—bone cancer	0.000322	0.0169	CcSEcCtD
Chlorphenamine—Promazine—CYP3A4—bone cancer	0.000306	0.0698	CrCbGaD
Chlorphenamine—Neuropathy peripheral—Cisplatin—bone cancer	0.000289	0.0151	CcSEcCtD
Chlorphenamine—Dyskinesia—Epirubicin—bone cancer	0.000288	0.0151	CcSEcCtD
Chlorphenamine—Chlorpromazine—CYP3A4—bone cancer	0.000269	0.0614	CrCbGaD
Chlorphenamine—Dyskinesia—Doxorubicin—bone cancer	0.000267	0.0139	CcSEcCtD
Chlorphenamine—Tinnitus—Cisplatin—bone cancer	0.000247	0.0129	CcSEcCtD
Chlorphenamine—Photosensitivity—Methotrexate—bone cancer	0.000239	0.0125	CcSEcCtD
Chlorphenamine—Mental disability—Epirubicin—bone cancer	0.000235	0.0123	CcSEcCtD
Chlorphenamine—Photosensitivity—Epirubicin—bone cancer	0.000224	0.0117	CcSEcCtD
Chlorphenamine—Mental disability—Doxorubicin—bone cancer	0.000217	0.0114	CcSEcCtD
Chlorphenamine—Vision blurred—Cisplatin—bone cancer	0.000217	0.0114	CcSEcCtD
Chlorphenamine—Tremor—Cisplatin—bone cancer	0.000216	0.0113	CcSEcCtD
Chlorphenamine—Photosensitivity—Doxorubicin—bone cancer	0.000207	0.0108	CcSEcCtD
Chlorphenamine—Irritability—Methotrexate—bone cancer	0.000201	0.0105	CcSEcCtD
Chlorphenamine—Convulsion—Cisplatin—bone cancer	0.0002	0.0104	CcSEcCtD
Chlorphenamine—Diplopia—Epirubicin—bone cancer	0.000197	0.0103	CcSEcCtD
Chlorphenamine—Anxiety—Cisplatin—bone cancer	0.000196	0.0102	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Cisplatin—bone cancer	0.000184	0.00964	CcSEcCtD
Chlorphenamine—Tachycardia—Cisplatin—bone cancer	0.000184	0.00961	CcSEcCtD
Chlorphenamine—Diplopia—Doxorubicin—bone cancer	0.000182	0.00952	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Cisplatin—bone cancer	0.000182	0.00951	CcSEcCtD
Chlorphenamine—Anorexia—Cisplatin—bone cancer	0.000179	0.00938	CcSEcCtD
Chlorphenamine—Hypotension—Cisplatin—bone cancer	0.000176	0.0092	CcSEcCtD
Chlorphenamine—Paraesthesia—Cisplatin—bone cancer	0.000169	0.00884	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Methotrexate—bone cancer	0.000166	0.00867	CcSEcCtD
Chlorphenamine—Decreased appetite—Cisplatin—bone cancer	0.000164	0.00856	CcSEcCtD
Chlorphenamine—Drowsiness—Methotrexate—bone cancer	0.000162	0.00847	CcSEcCtD
Chlorphenamine—Pollakiuria—Epirubicin—bone cancer	0.000157	0.00821	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Epirubicin—bone cancer	0.000155	0.00811	CcSEcCtD
Chlorphenamine—Feeling abnormal—Cisplatin—bone cancer	0.000155	0.00811	CcSEcCtD
Chlorphenamine—Drowsiness—Epirubicin—bone cancer	0.000152	0.00792	CcSEcCtD
Chlorphenamine—Agranulocytosis—Methotrexate—bone cancer	0.000151	0.0079	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Epirubicin—bone cancer	0.000149	0.00777	CcSEcCtD
Chlorphenamine—Pollakiuria—Doxorubicin—bone cancer	0.000145	0.0076	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000144	0.00751	CcSEcCtD
Chlorphenamine—Agranulocytosis—Epirubicin—bone cancer	0.000141	0.0074	CcSEcCtD
Chlorphenamine—Drowsiness—Doxorubicin—bone cancer	0.00014	0.00733	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000137	0.00719	CcSEcCtD
Chlorphenamine—Tinnitus—Methotrexate—bone cancer	0.000136	0.00709	CcSEcCtD
Chlorphenamine—Asthenia—Cisplatin—bone cancer	0.000135	0.00706	CcSEcCtD
Chlorphenamine—Agranulocytosis—Doxorubicin—bone cancer	0.000131	0.00684	CcSEcCtD
Chlorphenamine—Chills—Methotrexate—bone cancer	0.00013	0.00682	CcSEcCtD
Chlorphenamine—Diarrhoea—Cisplatin—bone cancer	0.000129	0.00673	CcSEcCtD
Chlorphenamine—Tinnitus—Epirubicin—bone cancer	0.000127	0.00663	CcSEcCtD
Chlorphenamine—Chills—Epirubicin—bone cancer	0.000122	0.00638	CcSEcCtD
Chlorphenamine—Vomiting—Cisplatin—bone cancer	0.00012	0.00626	CcSEcCtD
Chlorphenamine—Vision blurred—Methotrexate—bone cancer	0.000119	0.00624	CcSEcCtD
Chlorphenamine—Tinnitus—Doxorubicin—bone cancer	0.000117	0.00614	CcSEcCtD
Chlorphenamine—Tension—Epirubicin—bone cancer	0.000116	0.00608	CcSEcCtD
Chlorphenamine—Nervousness—Epirubicin—bone cancer	0.000115	0.00601	CcSEcCtD
Chlorphenamine—Vertigo—Methotrexate—bone cancer	0.000114	0.00595	CcSEcCtD
Chlorphenamine—Chills—Doxorubicin—bone cancer	0.000113	0.00591	CcSEcCtD
Chlorphenamine—Nausea—Cisplatin—bone cancer	0.000112	0.00585	CcSEcCtD
Chlorphenamine—Vision blurred—Epirubicin—bone cancer	0.000112	0.00584	CcSEcCtD
Chlorphenamine—Convulsion—Methotrexate—bone cancer	0.00011	0.00573	CcSEcCtD
Chlorphenamine—Agitation—Epirubicin—bone cancer	0.000109	0.00569	CcSEcCtD
Chlorphenamine—Tension—Doxorubicin—bone cancer	0.000108	0.00562	CcSEcCtD
Chlorphenamine—Nervousness—Doxorubicin—bone cancer	0.000106	0.00557	CcSEcCtD
Chlorphenamine—Vertigo—Epirubicin—bone cancer	0.000106	0.00556	CcSEcCtD
Chlorphenamine—Palpitations—Epirubicin—bone cancer	0.000105	0.00547	CcSEcCtD
Chlorphenamine—Confusional state—Methotrexate—bone cancer	0.000104	0.00545	CcSEcCtD
Chlorphenamine—Vision blurred—Doxorubicin—bone cancer	0.000103	0.0054	CcSEcCtD
Chlorphenamine—Convulsion—Epirubicin—bone cancer	0.000103	0.00537	CcSEcCtD
Chlorphenamine—Hypertension—Epirubicin—bone cancer	0.000102	0.00535	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Methotrexate—bone cancer	0.000101	0.00529	CcSEcCtD
Chlorphenamine—Agitation—Doxorubicin—bone cancer	0.000101	0.00527	CcSEcCtD
Chlorphenamine—Anxiety—Epirubicin—bone cancer	0.0001	0.00525	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Methotrexate—bone cancer	9.98e-05	0.00522	CcSEcCtD
Chlorphenamine—Dry mouth—Epirubicin—bone cancer	9.86e-05	0.00516	CcSEcCtD
Chlorphenamine—Vertigo—Doxorubicin—bone cancer	9.84e-05	0.00515	CcSEcCtD
Chlorphenamine—Anorexia—Methotrexate—bone cancer	9.84e-05	0.00515	CcSEcCtD
Chlorphenamine—Confusional state—Epirubicin—bone cancer	9.74e-05	0.0051	CcSEcCtD
Chlorphenamine—Palpitations—Doxorubicin—bone cancer	9.68e-05	0.00506	CcSEcCtD
Chlorphenamine—Hypotension—Methotrexate—bone cancer	9.65e-05	0.00505	CcSEcCtD
Chlorphenamine—Convulsion—Doxorubicin—bone cancer	9.49e-05	0.00496	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Epirubicin—bone cancer	9.46e-05	0.00495	CcSEcCtD
Chlorphenamine—Hypertension—Doxorubicin—bone cancer	9.46e-05	0.00495	CcSEcCtD
Chlorphenamine—Tachycardia—Epirubicin—bone cancer	9.43e-05	0.00493	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Epirubicin—bone cancer	9.34e-05	0.00489	CcSEcCtD
Chlorphenamine—Insomnia—Methotrexate—bone cancer	9.34e-05	0.00488	CcSEcCtD
Chlorphenamine—Anxiety—Doxorubicin—bone cancer	9.3e-05	0.00486	CcSEcCtD
Chlorphenamine—Paraesthesia—Methotrexate—bone cancer	9.27e-05	0.00485	CcSEcCtD
Chlorphenamine—Anorexia—Epirubicin—bone cancer	9.21e-05	0.00482	CcSEcCtD
Chlorphenamine—Somnolence—Methotrexate—bone cancer	9.18e-05	0.0048	CcSEcCtD
Chlorphenamine—Dry mouth—Doxorubicin—bone cancer	9.12e-05	0.00477	CcSEcCtD
Chlorphenamine—Dyspepsia—Methotrexate—bone cancer	9.09e-05	0.00475	CcSEcCtD
Chlorphenamine—Hypotension—Epirubicin—bone cancer	9.03e-05	0.00472	CcSEcCtD
Chlorphenamine—Confusional state—Doxorubicin—bone cancer	9.02e-05	0.00472	CcSEcCtD
Chlorphenamine—Decreased appetite—Methotrexate—bone cancer	8.98e-05	0.00469	CcSEcCtD
Chlorphenamine—Fatigue—Methotrexate—bone cancer	8.9e-05	0.00466	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Doxorubicin—bone cancer	8.75e-05	0.00458	CcSEcCtD
Chlorphenamine—Insomnia—Epirubicin—bone cancer	8.74e-05	0.00457	CcSEcCtD
Chlorphenamine—Tachycardia—Doxorubicin—bone cancer	8.73e-05	0.00456	CcSEcCtD
Chlorphenamine—Paraesthesia—Epirubicin—bone cancer	8.68e-05	0.00454	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Doxorubicin—bone cancer	8.64e-05	0.00452	CcSEcCtD
Chlorphenamine—Somnolence—Epirubicin—bone cancer	8.59e-05	0.00449	CcSEcCtD
Chlorphenamine—Anorexia—Doxorubicin—bone cancer	8.52e-05	0.00446	CcSEcCtD
Chlorphenamine—Feeling abnormal—Methotrexate—bone cancer	8.51e-05	0.00445	CcSEcCtD
Chlorphenamine—Dyspepsia—Epirubicin—bone cancer	8.51e-05	0.00445	CcSEcCtD
Chlorphenamine—Decreased appetite—Epirubicin—bone cancer	8.4e-05	0.00439	CcSEcCtD
Chlorphenamine—Hypotension—Doxorubicin—bone cancer	8.36e-05	0.00437	CcSEcCtD
Chlorphenamine—Fatigue—Epirubicin—bone cancer	8.33e-05	0.00436	CcSEcCtD
Chlorphenamine—Constipation—Epirubicin—bone cancer	8.26e-05	0.00432	CcSEcCtD
Chlorphenamine—Insomnia—Doxorubicin—bone cancer	8.09e-05	0.00423	CcSEcCtD
Chlorphenamine—Paraesthesia—Doxorubicin—bone cancer	8.03e-05	0.0042	CcSEcCtD
Chlorphenamine—Feeling abnormal—Epirubicin—bone cancer	7.96e-05	0.00417	CcSEcCtD
Chlorphenamine—Somnolence—Doxorubicin—bone cancer	7.95e-05	0.00416	CcSEcCtD
Chlorphenamine—Dyspepsia—Doxorubicin—bone cancer	7.87e-05	0.00412	CcSEcCtD
Chlorphenamine—Decreased appetite—Doxorubicin—bone cancer	7.77e-05	0.00407	CcSEcCtD
Chlorphenamine—Fatigue—Doxorubicin—bone cancer	7.71e-05	0.00403	CcSEcCtD
Chlorphenamine—Constipation—Doxorubicin—bone cancer	7.65e-05	0.004	CcSEcCtD
Chlorphenamine—Asthenia—Methotrexate—bone cancer	7.41e-05	0.00387	CcSEcCtD
Chlorphenamine—Feeling abnormal—Doxorubicin—bone cancer	7.37e-05	0.00385	CcSEcCtD
Chlorphenamine—Diarrhoea—Methotrexate—bone cancer	7.07e-05	0.0037	CcSEcCtD
Chlorphenamine—Asthenia—Epirubicin—bone cancer	6.93e-05	0.00363	CcSEcCtD
Chlorphenamine—Dizziness—Methotrexate—bone cancer	6.83e-05	0.00357	CcSEcCtD
Chlorphenamine—Diarrhoea—Epirubicin—bone cancer	6.61e-05	0.00346	CcSEcCtD
Chlorphenamine—Vomiting—Methotrexate—bone cancer	6.57e-05	0.00343	CcSEcCtD
Chlorphenamine—Headache—Methotrexate—bone cancer	6.47e-05	0.00338	CcSEcCtD
Chlorphenamine—Asthenia—Doxorubicin—bone cancer	6.42e-05	0.00336	CcSEcCtD
Chlorphenamine—Dizziness—Epirubicin—bone cancer	6.39e-05	0.00334	CcSEcCtD
Chlorphenamine—Vomiting—Epirubicin—bone cancer	6.14e-05	0.00321	CcSEcCtD
Chlorphenamine—Nausea—Methotrexate—bone cancer	6.13e-05	0.00321	CcSEcCtD
Chlorphenamine—Diarrhoea—Doxorubicin—bone cancer	6.12e-05	0.0032	CcSEcCtD
Chlorphenamine—Headache—Epirubicin—bone cancer	6.05e-05	0.00317	CcSEcCtD
Chlorphenamine—Dizziness—Doxorubicin—bone cancer	5.91e-05	0.00309	CcSEcCtD
Chlorphenamine—Nausea—Epirubicin—bone cancer	5.74e-05	0.003	CcSEcCtD
Chlorphenamine—Vomiting—Doxorubicin—bone cancer	5.69e-05	0.00297	CcSEcCtD
Chlorphenamine—Headache—Doxorubicin—bone cancer	5.6e-05	0.00293	CcSEcCtD
Chlorphenamine—Nausea—Doxorubicin—bone cancer	5.31e-05	0.00278	CcSEcCtD
